These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 22641101)

  • 21. Anti-tumor and anti-metastatic actions of wogonin isolated from Scutellaria baicalensis roots through anti-lymphangiogenesis.
    Kimura Y; Sumiyoshi M
    Phytomedicine; 2013 Feb; 20(3-4):328-36. PubMed ID: 23219337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. COX-2 Induces Breast Cancer Stem Cells via EP4/PI3K/AKT/NOTCH/WNT Axis.
    Majumder M; Xin X; Liu L; Tutunea-Fatan E; Rodriguez-Torres M; Vincent K; Postovit LM; Hess D; Lala PK
    Stem Cells; 2016 Sep; 34(9):2290-305. PubMed ID: 27301070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclooxygenase-2 up-regulates CCR7 via EP2/EP4 receptor signaling pathways to enhance lymphatic invasion of breast cancer cells.
    Pan MR; Hou MF; Chang HC; Hung WC
    J Biol Chem; 2008 Apr; 283(17):11155-63. PubMed ID: 18319253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dual Blockade of EP2 and EP4 Signaling is Required for Optimal Immune Activation and Antitumor Activity Against Prostaglandin-Expressing Tumors.
    Francica BJ; Holtz A; Lopez J; Freund D; Chen A; Wang D; Powell D; Kipper F; Panigrahy D; Dubois RN; Whiting CC; Prasit P; Dubensky TW
    Cancer Res Commun; 2023 Aug; 3(8):1486-1500. PubMed ID: 37559947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclo-oxygenase inhibition reduces tumour growth and metastasis in an orthotopic model of breast cancer.
    Connolly EM; Harmey JH; O'Grady T; Foley D; Roche-Nagle G; Kay E; Bouchier-Hayes DJ
    Br J Cancer; 2002 Jul; 87(2):231-7. PubMed ID: 12107848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of cyclooxygenase-2 suppresses lymph node metastasis via reduction of lymphangiogenesis.
    Iwata C; Kano MR; Komuro A; Oka M; Kiyono K; Johansson E; Morishita Y; Yashiro M; Hirakawa K; Kaminishi M; Miyazono K
    Cancer Res; 2007 Nov; 67(21):10181-9. PubMed ID: 17974958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Soluble vascular endothelial growth factor receptor-3 suppresses lymphangiogenesis and lymphatic metastasis in bladder cancer.
    Yang H; Kim C; Kim MJ; Schwendener RA; Alitalo K; Heston W; Kim I; Kim WJ; Koh GY
    Mol Cancer; 2011 Apr; 10():36. PubMed ID: 21481239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Roles of a prostaglandin E-type receptor, EP3, in upregulation of matrix metalloproteinase-9 and vascular endothelial growth factor during enhancement of tumor metastasis.
    Amano H; Ito Y; Suzuki T; Kato S; Matsui Y; Ogawa F; Murata T; Sugimoto Y; Senior R; Kitasato H; Hayashi I; Satoh Y; Narumiya S; Majima M
    Cancer Sci; 2009 Dec; 100(12):2318-24. PubMed ID: 19799610
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of breast cancer growth and metastasis by a biomimetic peptide.
    Lee E; Lee SJ; Koskimaki JE; Han Z; Pandey NB; Popel AS
    Sci Rep; 2014 Nov; 4():7139. PubMed ID: 25409905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SIX1 induces lymphangiogenesis and metastasis via upregulation of VEGF-C in mouse models of breast cancer.
    Wang CA; Jedlicka P; Patrick AN; Micalizzi DS; Lemmer KC; Deitsch E; Casás-Selves M; Harrell JC; Ford HL
    J Clin Invest; 2012 May; 122(5):1895-906. PubMed ID: 22466647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclooxygenase-2 promotes tumor lymphangiogenesis and lymph node metastasis in oral squamous cell carcinoma.
    Morita Y; Hata K; Nakanishi M; Nishisho T; Yura Y; Yoneda T
    Int J Oncol; 2012 Sep; 41(3):885-92. PubMed ID: 22735610
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
    Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
    Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. COX-2 Elevates Oncogenic miR-526b in Breast Cancer by EP4 Activation.
    Majumder M; Landman E; Liu L; Hess D; Lala PK
    Mol Cancer Res; 2015 Jun; 13(6):1022-33. PubMed ID: 25733698
    [TBL] [Abstract][Full Text] [Related]  

  • 34. VEGF-C induced lymphangiogenesis is associated with lymph node metastasis in orthotopic MCF-7 tumors.
    Mattila MM; Ruohola JK; Karpanen T; Jackson DG; Alitalo K; Härkönen PL
    Int J Cancer; 2002 Apr; 98(6):946-51. PubMed ID: 11948478
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling.
    He Y; Kozaki K; Karpanen T; Koshikawa K; Yla-Herttuala S; Takahashi T; Alitalo K
    J Natl Cancer Inst; 2002 Jun; 94(11):819-25. PubMed ID: 12048269
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular inhibition of prostaglandin E2 with GW627368X: Therapeutic potential and preclinical safety assessment in mouse sarcoma model.
    Parida S; Parekh A; Dey G; Ghosh SC; Mandal M
    Cancer Biol Ther; 2015; 16(6):922-32. PubMed ID: 25894216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapy with siRNA for Vegf-c but not for Vegf-d suppresses wide-spectrum organ metastasis in an immunocompetent xenograft model of metastatic mammary cancer.
    Shibata MA; Shibata E; Morimoto J; Harada-Shiba M
    Anticancer Res; 2013 Oct; 33(10):4237-47. PubMed ID: 24122987
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential expression of E-type prostanoid receptors 2 and 4 in microglia stimulated with lipopolysaccharide.
    Bonfill-Teixidor E; Otxoa-de-Amezaga A; Font-Nieves M; Sans-Fons MG; Planas AM
    J Neuroinflammation; 2017 Jan; 14(1):3. PubMed ID: 28086956
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostaglandin E receptor EP4 is a therapeutic target in breast cancer cells with stem-like properties.
    Kundu N; Ma X; Kochel T; Goloubeva O; Staats P; Thompson K; Martin S; Reader J; Take Y; Collin P; Fulton A
    Breast Cancer Res Treat; 2014 Jan; 143(1):19-31. PubMed ID: 24281828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppression of lymphangiogenesis in human lymphatic endothelial cells by simultaneously blocking VEGF-C and VEGF-D/VEGFR-3 with norcantharidin.
    Liu ZY; Qiu HO; Yuan XJ; Ni YY; Sun JJ; Jing W; Fan YZ
    Int J Oncol; 2012 Nov; 41(5):1762-72. PubMed ID: 22922710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.